End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.92 CNY | -3.33% | -4.02% | +24.30% |
04-29 | Kanghong Pharmaceutical's Unit Gets US FDA's Green Light to Test Macular Degeneration Drug | MT |
04-29 | Kanghong Pharmaceutical's Unit Gets Nod to Trial Macular Degeneration Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+24.30% | 3.01B | |
+31.37% | 588B | |
-2.81% | 364B | |
+20.51% | 326B | |
+5.53% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.96% | 167B | |
+0.19% | 161B |
- Stock Market
- Equities
- 002773 Stock
- News Chengdu Kanghong Pharmaceutical Group Co., Ltd
- Kanghong Pharmaceutical's Unit Gets Nod to Trial Psoriasis Drug